CALB2 and endometrioid adenocarcinoma: The weak expression in endometrioid adenocarcinoma indicates that calretinin may not serve as a dependable diagnostic marker for endometrial cancers; however, its absence could assist in differentiating between certain benign and malignant conditions [27].